Agent-based modelling to simulate cell- and multiscale problems in biology - Minisymposium at ECCOMAS 2024
Our Technical Coordinator, Vasileios Vavourakis, and our Spokesperson, Roman Bauer, together with Mariam-Eleni Oraiopoulou, Arnau Montagud, Marco Manca, and Alfonso Caiazzo, are the organizers of the minisymposium "agent-based modelling to simulate cell- and multiscale problems in biology", at ECCOMAS, 3rd-7th June 2024, in Lisbon (Portugal).
The purpose of this minisymposium is to act as a forum for investigators to present the state of the art in ABM in biology and life sciences, with a focus on pathophysiology of chronic (e.g., neuro-developmental and neurodegenerative disorders, cancer, diabetes, chronic inflammation) and communicable diseases (viral infections, parasitic disorders, etc.). Together, we aim to foster the exchange of knowledge and ideas across multiple disciplines: mathematics, physics, computer science, engineering, biology, medicine.
We welcome contributions addressing challenges related to mathematical and computational modelling using ABM with particular emphasis in:
• cross-scale (from organ to tissue, cell, protein and molecular level) ABM simulations;
• challenges in numerical techniques –including high-performance computing procedures– for single scale or/and multiscale agent-based models;
• benchmarking and calibration of ABM in problems related to systems biology;
• simulations that integrate in vitro and/or in vivo laboratory experiments for ABM initialization, parametrization and/or validation;
• prognostic ABM in drug delivery, nanomedicine, immunotherapy, and radiation treatment, with special focus on optimisation of trials and in vivo/ex vivo models substitution/complementarity.
Abstracts submission is now open!!
Abstracts must be submitted electronically via the conference website. Below are a few important dates you might want to save on your calendar:
- January 15, 2024: Deadline for presenting a one page abstract
- March 18, 2024: Deadline for speaker registration
Comments
Post a Comment